NorthView Acquisition today closed its initial public offering of 18.975 million units, which included the full exercise of the underwriters’ over-allotment option. Units trade on the Nasdaq under the symbol NVACU.
Each unit consists of one share, one right, and one-half of a warrant. Each right entitles the holder to one-tenth of a share.
I-Bankers Securities was sole book-running manager of the offering and Dawson James Securities was co-manager.
The SPAC expects to target small-cap healthcare companies that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space. Read more.
